Search other companies ESG researched by sustainAX here
Dropdown Menu with Searchable Options

Stille AB – ESG risk research and ESG rating

We at sustainAX have ESG risk researched and ESG risk rated Stille AB and our clients can access the reseach on their Bloomberg terminals.

Stille AB is in the materiality based sector of PHARMA, BIOTECH AND LIFE SCIENCES.

sustainAX-ESG-E-S-and-G-risk-ratings
Our ESG risk research of Stille AB

Our approach to ESG research is fundamental, that means that we have studied all relevant publications by Stille AB and combined this with fundamental understanding of ESG challenges and risks of different activities and for the PHARMA, BIOTECH AND LIFE SCIENCES sector. This makes us well placed to estimate the ESG risks of Stille AB. We have published a 33 pages ESG research report on Stille AB with a conclusion highlighting the most important residual risks, a section suggesting how it should be integrated in investment decisions and a list of all the questions we think should be asked to Stille AB.

More about our ESG risk research here: https://www.sustainax.com/index.php/esg-research/

AGGREGATED ESG RISK RATING* for Stille AB:

40-60 of 100

Middle risk

Where 100 is the lowest ESG risk and 0 is the highest risk.

*The ESG, E, S and G risk rating ranges indicate to what degree Stille AB has addressed and mitigated their material ESG risks according to the sustainAX materiality matrix. sustainAX’ clients have access to the exact ESG risk rating. 

**The weight in the aggregated ESG rating

Environmental RISK RATING* and WEIGHT** for Stille AB:
0-20 of 100 Very High risk
19.56 %
Social RISK RATING* and WEIGHT** for Stille AB:
40-60 of 100 – Middle risk
35.47 %
Governance RISK RATING* and WEIGHT** for Stille AB:
60-80 of 100 – Low risk
44.96 %
About the company:

Stille AB (publ) was founded in 1841 and is thus one of the world's oldest medical technology companies. With the needs of the surgeon and the patient in focus, the Group develops, manufactures, markets and distributes medical devices that simplify and improve the care process. Stille's vision is to create the conditions for surgical perfection with its products: "Surgical Perfection. For Life". Product leadership is therefore central to the business, which is achieved, among other things, through solid product development in close collaboration with leading surgeons. "Today's STILLE is the result of 180 years of innovation in the service of healthcare. Ever since Albert Stille founded the company in 1841, the company has manufactured and marketed surgical instruments of premium quality that have enabled new types of operations and facilitated the work of surgeons. In 1887, Stille also began manufacturing and marketing operating tables, and is today the market leader in the segment of operating tables, which are used together with C-arm in minimally invasive vascular procedures. Operations are conducted in Sweden, the US and Switzerland with Group-wide functions in research and development, marketing, quality management, risk management and financial control.

Are you interested in the ESG research and ESG rating?

If you are interested in the ESG risk research and ESG risk rating of Stille AB, contact us at sustainAX!

© Copyright SustainAX AB and www.sustainax.com, 2024. Please note that by accessing and using the SustainAX AB website, you are consenting to comply with our Terms of Use and acknowledging the acceptance of any inherent risks. The content provided on this site is available for your non-commercial, non-competitive use, specifically for the purposes of understanding companies’ environmental, social, and governance (ESG) risks. Should you wish to employ our information within a professional capacity, it is incumbent upon you to secure the appropriate licensing rights from us. Be aware that any form of unauthorised data extraction or the systematic electronic harvesting of our content is expressly forbidden.

Generated by MPG